NCT04272333 2022-04-14Intratumoral Microdosing of Motolimod in HNSCCPresage BiosciencesPhase EARLY_PHASE1 Terminated1 enrolled
NCT02124850 2019-10-25A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus NivolumabCelgenePhase 1 Terminated18 enrolled